Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple Sclerosis
Clinical trial NCT04966338 · COMPLETED
Trial details
- NCT number
- NCT04966338
- Sponsor
- Cinnagen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-19
- Primary completion
- 2020-11-09
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.